The Private Markets Update highlights key developments emerging from private markets across Europe, the UK and the United States, exploring the cross-border issues that matter to investors and sponsors in alternative assets. ...more
10/16/2024
/ Acquisitions ,
Artificial Intelligence ,
Capital Markets ,
Cross-Border ,
EU ,
EUMR ,
Financial Conduct Authority (FCA) ,
Greenwashing ,
Healthcare ,
Investment ,
Investment Management ,
Investors ,
Life Sciences ,
Mergers ,
Private Equity ,
Regulatory Agenda ,
Regulatory Requirements ,
UK ,
United States
Companies House, the UK’s official company register, has recently come under the spotlight due to a series of rogue filings that have affected over 190 companies, including several high-profile organizations such as...more
200+ leading individuals in healthcare, life sciences and private equity gathered at the Shangri-La Hotel in Paris for the European Health & Life Sciences Symposium 2023 to enjoy a day packed with fireside chats, in-depth...more
11/28/2023
/ Artificial Intelligence ,
Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Information Technology ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
Welcome to the inaugural Private Markets Update, which highlights developments in the European private markets, covering the issues that matter to investors in alternative assets. Touching on themes as diverse as predictions...more
5/31/2023
/ Acquisitions ,
Capital Markets ,
Cross-Border ,
EU ,
FinTech ,
Germany ,
Investment ,
Investors ,
Mergers ,
National Security ,
OECD ,
Pillar 2 ,
Private Equity ,
Private Equity Funds ,
Restructuring ,
UK
Key Trends & Opportunities in Life Sciences and Healthcare Investing -
The current macroeconomic environment is creating challenges for healthcare and life sciences businesses, which have been impacted hard by wage...more
12/9/2022
/ Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
After an insightful conference in Cannes, our partners have compiled some of the key takeaways from IPEM 2022.
As well as exploring the private equity landscape in the UK, Germany, France and Italy, we also explore the...more
10/25/2022
/ Acquisitions ,
Debt ,
Economic Growth ,
Environmental Social & Governance (ESG) ,
EU ,
France ,
Funding ,
Germany ,
Healthcare ,
Investment ,
Investors ,
Italy ,
Mergers ,
Private Equity ,
Publicly-Traded Companies ,
Small and Medium-Sized Enterprises (SMEs) ,
UK ,
Venture Capital
After a year during which uncertainty in the equity markets became the new normal, many stakeholders are wondering whether the disruptions are behind us. A look at key indicators might lead one to say yes. The S&P Loan Index...more
8/4/2021
/ Borrowers ,
Coronavirus/COVID-19 ,
Environmental Social & Governance (ESG) ,
Equity Markets ,
EU ,
European Banking Authority (EBA) ,
Financial Services Industry ,
Financial Stimulus ,
Healthcare ,
Liquidity ,
UK
On 5 March 2021, the Financial Conduct Authority (FCA) set out certain key dates for the cessation of all 35 London Inter-Bank Offered Rate (LIBOR) settings published by ICE Benchmark Administration. Whilst there has been...more
On 24 February 2021, the UK government laid The Administration (Restrictions on Disposal etc. to Connected Persons) Regulations 2021 before Parliament.
These draft regulations introduce (among other items) new restrictions...more
Last year presented a great many challenges, and much like 2008–2009, the impact was felt on a global basis. The last quarter of 2020 appeared to start with a sense of renewed optimism, with the end of pandemic-driven issues...more
1/28/2021
/ Biden Administration ,
Coronavirus/COVID-19 ,
Debt Restructuring ,
Equity Markets ,
EU ,
Global Economy ,
Global Market ,
New Legislation ,
Private Equity ,
UK ,
United States
Cram-Down There has been much commentary on the new restructuring plan which is modelled on the existing scheme of arrangement but includes cross-class cram-down powers afforded under section 901G of the new Part26A of the...more
The enacted Corporate Insolvency and Governance Act (the Act) introduces three permanent reforms to the existing insolvency legislation and certain temporary measures designed to address the immediate impact of COVID-19 on UK...more
9/1/2020
/ Business Closures ,
Business Interruption ,
Chapter 11 ,
Coronavirus/COVID-19 ,
Corporate Insolvency and Governance (CIG) Act 2020 ,
Debt Restructuring ,
Financial Distress ,
Investors ,
Legislative Agendas ,
Lenders ,
Liquidity ,
Restructuring ,
UK
On 20 May 2020, the Corporate Insolvency and Governance Bill (the Bill) was introduced to the House of Commons for its first reading, with the aim of completing all its stages in the Commons and progressing through the House...more
Three months into the outbreak of the Coronavirus (COVID-19) in the United Kingdom, there are clearly many unknowns as businesses seek a return to normality or, at the very least, economic stability. Such uncertainty may...more
5/31/2020
/ Acquisitions ,
Board of Directors ,
Business Interruption ,
Business Model ,
CFOs ,
Coronavirus/COVID-19 ,
Employee Engagement ,
Inventory ,
Liquidity Management ,
Mergers ,
Supply Chain ,
Tax Structuring ,
UK
During these unprecedented times, many funds seek opportunities to deploy capital, with a particular focus on the “special situations” space. A certain amount of heightened risk (or risk perception) in this economic climate...more